» Articles » PMID: 38408788

Genomic Origin, Fragmentomics, and Transcriptional Properties of Long Cell-free DNA Molecules in Human Plasma

Abstract

Recent studies have revealed an unexplored population of long cell-free DNA (cfDNA) molecules in human plasma using long-read sequencing technologies. However, the biological properties of long cfDNA molecules (>500 bp) remain largely unknown. To this end, we have investigated the origins of long cfDNA molecules from different genomic elements. Analysis of plasma cfDNA using long-read sequencing reveals an uneven distribution of long molecules from across the genome. Long cfDNA molecules show overrepresentation in euchromatic regions of the genome, in sharp contrast to short DNA molecules. We observe a stronger relationship between the abundance of long molecules and mRNA gene expression levels, compared with short molecules (Pearson's = 0.71 vs. -0.14). Moreover, long and short molecules show distinct fragmentation patterns surrounding CpG sites. Leveraging the cleavage preferences surrounding CpG sites, the combined cleavage ratios of long and short molecules can differentiate patients with hepatocellular carcinoma (HCC) from non-HCC subjects (AUC = 0.87). We also investigated knockout mice in which selected nuclease genes had been inactivated in comparison with wild-type mice. The proportion of long molecules originating from transcription start sites are lower in -deficient mice but higher in -deficient mice compared with that of wild-type mice. This work thus provides new insights into the biological properties and potential clinical applications of long cfDNA molecules.

Citing Articles

Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.

Bruhm D, Vulpescu N, Foda Z, Phallen J, Scharpf R, Velculescu V Nat Rev Cancer. 2025; .

PMID: 40038442 DOI: 10.1038/s41568-025-00795-x.


Blood biomarkers of hepatocellular carcinoma: a critical review.

Zhao J, Hu Z, Zheng X, Lin Y, Liu X, Zhang J Front Cell Dev Biol. 2024; 12:1489836.

PMID: 39650722 PMC: 11621223. DOI: 10.3389/fcell.2024.1489836.


Advances in early detection of non-small cell lung cancer: A comprehensive review.

Kenaan N, Hanna G, Sardini M, Iyoun M, Layka K, Hannouneh Z Cancer Med. 2024; 13(18):e70156.

PMID: 39300939 PMC: 11413414. DOI: 10.1002/cam4.70156.


Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes.

Sirajee A, Kabiraj D, De S Transl Oncol. 2024; 49:102085.

PMID: 39178576 PMC: 11388671. DOI: 10.1016/j.tranon.2024.102085.


Systematically Evaluating Cell-Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation Patterns.

Hou Y, Meng X, Zhou X Adv Sci (Weinh). 2024; 11(30):e2308243.

PMID: 38881520 PMC: 11321639. DOI: 10.1002/advs.202308243.

References
1.
Bouwman B, Agostini F, Garnerone S, Petrosino G, Gothe H, Sayols S . Genome-wide detection of DNA double-strand breaks by in-suspension BLISS. Nat Protoc. 2020; 15(12):3894-3941. DOI: 10.1038/s41596-020-0397-2. View

2.
Ulz P, Perakis S, Zhou Q, Moser T, Belic J, Lazzeri I . Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nat Commun. 2019; 10(1):4666. PMC: 6789008. DOI: 10.1038/s41467-019-12714-4. View

3.
Ballarino R, Bouwman B, Agostini F, Harbers L, Diekmann C, Wernersson E . An atlas of endogenous DNA double-strand breaks arising during human neural cell fate determination. Sci Data. 2022; 9(1):400. PMC: 9276747. DOI: 10.1038/s41597-022-01508-x. View

4.
Mouliere F, Chandrananda D, Piskorz A, Moore E, Morris J, Ahlborn L . Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018; 10(466). PMC: 6483061. DOI: 10.1126/scitranslmed.aat4921. View

5.
Eisenberg E, Levanon E . Human housekeeping genes, revisited. Trends Genet. 2013; 29(10):569-74. DOI: 10.1016/j.tig.2013.05.010. View